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Exploring whether the positive association between birth weight and breast cancer risk differs by other breast cancer risk factors may
help inform speculation about biological mechanism. In these data, high birth weight was associated with breast cancer risk in younger
and in more educated women, but was not associated overall.
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Many, but not all studies of birth weight and subsequent breast
cancer risk suggest a positive association, with the most consistent
finding being an association in younger or premenopausal women,
often with either no or a reduced association among postmeno-
pausal women (Ekbom et al, 1992; Michels et al, 1996; Sanderson
et al, 1996; De Stavola et al, 2000; Innes et al, 2000; Andersson et al,
2001; Hilakivi-Clarke et al, 2001; Titus-Ernstoff et al, 2002; Vatten
et al, 2002, 2005; Ahlgren et al, 2003; Kaijser et al, 2003;
McCormack et al, 2003; Mellemkjær et al, 2003; dos Santos Silva
et al, 2004; Lahmann et al, 2004).
We evaluated the association of birth weight and breast cancer
risk in the National Cancer Institute’s (NCI) Combined Diethyl-
stilbestrol (DES) Cohorts Follow-up Study. The strengths of this
resource are the availability of weight from birth records, adult
breast cancer risk factor data from three phases of questionnaire
follow-up, and a subset of the population receiving very high
pharmacologic doses of oestrogen, which could inform some of the
speculation about possible hormonal mechanisms.
MATERIALS AND METHODS
Approvals for the study were obtained from the committees for the
review of research involving human subjects at the field centres
and the NCI.
The NCI DES Combined Cohort Study started in 1992 with the
aggregation of prior US cohorts of individuals with medical record
documentation of DES exposure and a comparable cohort of
unexposed women (Bibbo et al, 1977; Labarthe et al, 1978;
Greenberg et al, 1984). Questionnaires were mailed to participants
in 1994, 1997, and 2001, and the National Death Index (NDI)-Plus
was used to identify women whose whereabouts were unknown. Of
the 5847 eligible subjects with birth weight data who were free of
breast cancer at the start of follow-up, 97 developed breast cancer
and 1245 were lost before the end of follow-up in 2001; the
remaining 4505 were followed through the 2001 data collection
phase. Incident cases of breast cancer were identified through
questionnaire self-reports and searches of the NDI-Plus. Pathology
reports or death certificates were obtained for 91% of the reported
breast cancer cases eligible for analysis, confirming invasive
disease in 88% and in situ disease in an additional 11%. Only
primary invasive cases were analysed.
Data on birth weight and gestational age were available from
obstetrical charts for 80% of the women. For the remaining 20%,
these data were ascertained from the mothers at the time of their
daughter’s original enrollment in the study (the average age of the
daughters¼24 years). Information on covariates was obtained
from the study questionnaires, obstetrical records or interviews, or
from earlier questionnaires from the original cohort studies.
Follow-up began on 1 January 1978 (or the date of first
enrollment if it occurred later). Person-years accrued until the
earliest of the following dates: first breast cancer diagnosis, last
known follow-up, death, or return of the 2001 questionnaire. The
median number of follow-up years was 23.5 (0.1–25.9 years) for a
total of 118985 person-years.
Poisson regression analysis was used to estimate the age-
adjusted incidence rate ratios of breast cancer for each category of
birth weight and gestational age. A test for trend was assessed by
using an ordinal variable for the birth weight categories. To assess
confounding, estimates were individually adjusted for each of the
covariates. As a hypothesis-generating exercise, interactions of
birth weight with the collected covariates were assessed.
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Birth weight was not associated with attained age, age at first birth/
parity, menopausal status, or family history of breast cancer, but
was inversely associated with mother’s smoking status and use of
DES during pregnancy (Table 1). An inverse association between
birth weight and age at menarche was also suggested. Birth weight
tended to be positively associated with adult height (r¼0.25,
Po0.0001), BMI (r¼0.03, P¼0.06), and BMI at age 20 (r¼0.04,
P¼0.01).
Overall, there was no association between birth weight and
breast cancer risk comparing women who weighed o3000g (rate
ratio (RR)¼0.93) or 43500g (RR¼1.09) with women who
weighed 3000–3499g at birth (P for trend¼0.69) (Table 2), and
there was no obvious pattern in the association of gestational age
with breast cancer incidence (P for trend¼0.66). These results
Table 1 Distribution of characteristics (person-years (%)) by birth weight category
Birth weight (g)
o3000 3000–3499 3500+
Characteristic 42054 46398 30533
Cohort
DESAD 37246 (36.1) 39900 (38.6) 26000 (25.2)
Dieckmann 4006 (29.3) 5695 (41.7) 3943 (28.8)
WHS offspring 802 (36.5) 803 (36.8) 589 (26.8)
Age (years)
o40 28690 (35.7) 31027 (38.6) 20495 (25.5)
40+ 13364 (34.4) 15371 (39.6) 10038 (25.8)
Education
Some college or less 14530 (35.2) 15286 (37.1) 11412 (27.7)
Completed college 12853 (35.4) 14146 (38.9) 9308 (25.6)
Graduate school 10959 (37.0) 12002 (40.5) 6643 (22.4)
Missing 3712 (31.3) 4964 (41.9) 3169 (27.6)
Age at menarche (years)
o¼11 7023 (33.6) 7196 (38.0) 4399 (28.2)
12–13 25222 (35.3) 28179 (39.5) 17907 (25.1)
14+ 9599 (37.7) 10833 (38.6) 8052 (23.6)
Missing 211 (36.6) 190 (33.0) 174 (30.3)
Parity
Nulliparous 19705 (37.0) 20338 (38.1) 13212 (24.8)
Age at first birth o30 years 16005 (33.8) 18695 (39.5) 12544 (26.5)
Age at first birth 30+ years 4831 (33.6) 5899 (41.0) 3637 (25.3)
Missing 1513 (36.7) 1466 (35.6) 1139 (27.6)
Menopausal status
Premenopausal 35152 (35.5) 38500 (38.9) 25154 (25.4)
Postmenopausal 3063 (34.5) 3533 (39.8) 2261 (25.5)
Unknown/censored 3839 (33.9) 4365 (38.5) 3118 (27.5)
Height (in)
o66 27259 (41.8) 24940 (38.3) 12869 (19.7)
66+ 13660 (27.0) 19993 (39.6) 16775 (33.2)
Missing 1135 (32.5) 1466 (42.0) 889 (25.4)
Body mass index
o25 28434 (36.3) 30740 (39.3) 18972 (24.2)
25+ 12379 (33.4) 14142 (38.2) 10488 (28.3)
Missing 1241 (34.5) 1517 (38.8) 1073 (26.5)
Mother’s smoking status during pregnancy
No 18546 (29.4) 25302 (40.1) 19129 (30.3)
Yes 18261 (45.9) 14629 (36.8) 6833 (17.2)
Missing 5247 (32.2) 6468 (39.7) 4571 (28.0)
DES exposure
No 7238 (25.0) 12234 (42.3) 9395 (32.5)
Yes 34816 (38.6) 34164 (37.9) 21138 (23.4)
Family history of breast cancer
No 35022 (35.8) 37984 (38.8) 24680 (25.2)
Yes 4871 (34.1) 5588 (39.1) 3821 (26.7)
Missing 2161 (30.7) 2827 (40.2) 2031 (28.9)
DES¼diethylstilbestrol.
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age in the birth weight models, or age and birth weight in the
gestational age models (data not shown). Estimates changed less
than 10% with further adjustment individually for calendar year,
and the variables listed in Table 1 (data not shown). With a more
detailed examination of birth weight, the RR were 1.3, 0.82, 1.1,
and 1.1 for o2500g, 2500–3000g, 3500–3999g, and greater than
4000g compared with 3000–3499g.
Among women under the age of 40 years, the RR for women
who weighed 43500g at birth was 2.19 (95% confidence interval
(CI) 0.83–5.7) compared with those who weighed 3000–3500g
(Table 3). As the CI indicates, this was an imprecise estimate,
based on only 10 cases. High birth weight was associated with an
elevated breast cancer risk in highly educated women but a
reduction in risk in the less-educated women (P for inter-
action¼0.004). However, neither of the estimates was statistically
significant and the latter was based on only two exposed cases.
There was no evidence of interaction in the association of birth
weight with breast cancer incidence by any other breast cancer risk
factor, including in utero DES exposure, although there were few
cases in many of these subanalyses reflected by unstable estimates
and wide CIs (data not shown). In analyses restricted to the DES-
exposed women, the risk estimates for birth weight and breast
cancer by education and age strata were similar to those observed
in the combined group of exposed and unexposed women (data
not shown).
DISCUSSION
Most studies find evidence of a positive association between birth
weight and breast cancer risk, but several have not (Ekbom et al,
1997; Sanderson et al, 1998, 2002; Titus-Ernstoff et al, 2002;
Hodgson et al, 2004). Although not associated overall in our data,
risk was elevated, albeit not statistically significantly, with high
birth weight in younger women consistent with previous observa-
tions (Michels et al, 1996; Sanderson et al, 1996; De Stavola et al,
2000; Innes et al, 2000; Mellemkjær et al, 2003; McCormack et al,
2005).
The effect of birth weight varied by level of education with an
increased risk for high birth weight in more educated women and
an apparent risk reduction in the less-educated women. While
earlier studies controlled for social class (Ekbom et al, 1997; De
Stavola et al, 2000; Sanderson et al, 2002; Vatten et al, 2002, 2005;
Titus-Ernstoff et al, 2002; McCormack et al, 2003, 2005; Lahmann
et al, 2004; Lahmann et al, 2004; dos Santos Silva et al, 2004), none
found evidence of confounding of the birth weight and breast
cancer association. Only one investigated the interaction of birth
weight and education (Titus-Ernstoff et al, 2002), reporting a
stronger association of high birth weight with breast cancer risk in
women whose fathers were the most educated. As discussed
elsewhere (Hodgson et al, 2004), most studies have been
conducted in Caucasians from high-risk populations. Results from
studies in a relatively disadvantaged population in the US
(Hodgson et al, 2004) and in Chinese women with limited
education (Sanderson et al, 2002) suggest an inverse association
of birth weight and breast cancer. If the association of birth weight
with breast cancer differs by social class, this might explain some
of the heterogeneity of findings reported in the literature on birth
weight and breast cancer risk. It would be useful to know if any of
the other studies with information on socioeconomic status have
similar findings.
If the positive association of birth weight and breast cancer risk
observed among younger women and those with more education is
real and reflects differences in biology, our observation argues
against the hypothesis that the operable mechanism is mediated
through higher levels of oestrogen. Most of these women (and all
in the analyses restricted to DES-exposed women), regardless of
their birth weight, received pharmacologic doses of oestrogen
during prenatal breast development. Recent observations that cord
blood estrogen levels – reflecting fetal exposure – are not
associated with birth weight (Troisi et al, 2003) also undermine
the proposed oestrogen mechanism.
In conclusion, while there was no overall association, we found
an elevated risk of breast cancer with high birth weight among
younger women and those of higher educational attainment,
findings consistent with several other observations. If true, these
subgroup differences might explain some of the inconsistencies
between existing studies of this relationship. In addition, the
Table 2 Rate ratios (RR) and 95% confidence intervals (CI) for breast
cancer according to birth weight and gestational age
No. of
cases
No. of
person-years
Age-adjusted
RR
95%
CI
Birth weight (g)
o3000 32 42054 0.98 (0.61–1.6)
3000–3499 38 46399 1.0 —
3500+ 27 30533 1.09 (0.66–1.8)
Gestational age (weeks)
o39 21 34983 0.77 (0.42–1.4)
39 28 23491 1.38 (0.78–2.4)
40 21 24246 1.0 —
41+ 13 21772 0.68 (0.34–1.4)
Missing 14 14493 1.33 (0.67–2.6)
Table 3 Rate ratios (RR) and 95% confidence intervals (CI) for birth
weight (g) and breast cancer by age, education
a,b and DES exposure
No. of
cases
Age-adjusted
RR
95%
CI
Ageo40 years
o3000 7 1.12 (0.39–3.2)
3000–3499 7 1.0 —
3500+ 10 2.19 (0.83–5.7)
Age 40+ years
o3000 25 0.95 (0.56–1.6)
3000–3499 31 1.0 —
3500+ 17 0.84 (0.46–1.5)
o4 years of college
o3000 16 1.09 (0.55–2.2)
3000–3499 16 1.0 —
3500+ 2 0.17 (0.04–0.74)
4 years of college
o3000 7 0.75 (0.29–1.9)
3000–3499 11 1.0 —
3500+ 9 1.27 (0.52–3.1)
Graduate school
o3000 7 1.05 (0.38–2.9)
3000–3499 8 1.0 —
3500+ 10 2.27 (0.90–5.8)
DES exposed
o3000 15 0.88 (0.51–1.5)
3000–3499 29 1.0
3500+ 18 1.01 (0.56–1.8)
DES unexposed
o3000 7 1.32 (0.49–3.5)
3000–3499 9 1.0 1.0
3500+ 9 1.36 (0.54–3.4)
aTests for interaction: P¼0.22 for age, P¼0.004 for education, and P40.50 for DES
exposure.
bEleven cases were missing education. DES¼diethylstilbestrol.
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against the popular hypothesis that such a mechanism is oestrogen
mediated.
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